Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations

EFPIA Newsletter 21 March 2019


After Brexit, will patients get the medicines they need?

By Stefan Oschmann

Stefan Oschmann, EFPIA President, Chairman of the Executive Board and CEO of Merck

Since the UK public voted to leave the European Union, the potential impact on our healthcare systems has begun to loom large. For most sectors, the issues around Brexit are economic. But medicines are different. As the research-based pharmaceutical industry, the medicines we make improve the quality of life, often save the lives of patients in the UK and across Europe. For us, the primary concern around Brexit has always been patient safety and public health, in particular the uninterrupted supply of medicines to patients in the 27 EU Member States and the United Kingdom. Read more




Bold vision needed to translate basic health research in to new ways of delivering healthcare...
19 March 2019

BioMed Alliance and EFPIA have teamed up to address the gaps within the translational research ecosystem and call for... Read more




#ForTheChance to live a normal life (Guest Blog)
13 March 2019

The story of Boyan, living with haemophilia B Read more




European Excellence: Making the EU a world leader in medical R&D
We want Europe to be the world leader in medical R&D. The pharmaceutical industry created a trade surplus of €79.7... Read more

Children keep us up at night
And #WeWontRest until we’ve helped make the world a  healthier place for every single one of them Read more




IMI Stakeholder Forum 2019
12 June 2019 (Royal Museums of Fine Arts of Belgium)

Brain health and disease in the digital era - 2020 and beyond Read more

ICHOM conference 2019: Redefining value through patient centered outcomes
02 May 2019 (Rotterdam, The Netherlands)

The world-leading event for providers, life sciences and industry on value-based healthcare Read more


What we are reading


EU urged to safeguard post-Brexit medical supplies from UK
On 20 March 2019 (Financial Times)

European pharmaceutical leaders have called on EU member states to do more to safeguard the supply of medicines post-Brexit,... Read more

The Innovative Medicines Initiative launches a public-private coordination and support action...
On 21 March 2019 (Alzheimer Europe)

Today, the members of the NEURONET project announced the start of a new collaborative pan-European coordination and... Read more

Falsified medicines: new rules to enhance patients' safety
On 15 January 2019 (European Commission)

The falsification of medicines has remained a serious threat to public health in the EU for too long. As of 9 February... Read more